SoFi Technologies' share price closed at $18.61 on March 3, 2026, after announcing an expanded partnership that will allow its SoFiUSD stablecoin to be used as a settlement option on Mastercard's global payments network. The company also disclosed that CEO Anthony Noto purchased roughly $1 million of SOFI stock in the open market, coinciding with a premarket rise to $19.23 on March 4. SoFiUSD, issued by SoFi Bank, N.A., is fully cash-reserved and is expected to support around-the-clock settlement for SoFi's card transactions.

Dycom Industries, Bath & Body Works, and Abercrombie & Fitch all posted fourth‑quarter results that came in ahead of analyst expectations, with revenue and EPS generally beating forecasts. Dycom reported record contract revenue and EPS, Bath & Body Works delivered higher‑than‑guided profitability despite slightly lower sales, and Abercrombie achieved record quarterly and full‑year net sales. Each company also issued full‑year outlooks, with Dycom and Abercrombie projecting continued growth and Bath & Body Works guiding to lower sales but resilient earnings.

On March 2, 2026, American Express' Board of Directors approved a 16% increase in its quarterly dividend, lifting the payout from $0.82 to $0.95 per share and setting an annualized dividend of $3.80. As of March 3, 2026, AXP stock trades near $307.43, down about 16.71% year-to-date despite double-digit earnings growth and a payout ratio of roughly 21.6%. The combination of dividend hikes, ongoing buybacks, and recent share-price weakness presents both opportunities and risks for income-oriented investors.

Best Buy reported fourth-quarter fiscal 2026 adjusted diluted EPS of $2.61, beating the $2.47 consensus, while revenue of $13.81 billion came in slightly below the $13.91 billion estimate. The retailer improved its operating margin to 5.2% from 1.6% a year earlier and issued fiscal 2027 guidance calling for $41.2 billion to $42.1 billion in revenue and adjusted EPS of $6.30 to $6.60.

American Airlines Group Inc.'s AAL shares traded lower in premarket on March 3, 2026, after closing down 4.21% at $12.52 the prior session. The stock slipped to $12.06 before the open as military action in the Middle East triggered widespread flight disruptions and pushed Brent crude about 8% higher to $78.77 per barrel, pressuring airline margins and sentiment across the sector.

Paramount Skydance Corporation stock moved lower after the company outlined financial terms of its $110 billion merger with Warner Bros. Discovery, which will leave the combined group with about $79 billion in net debt. Executives projected significant revenue, EBITDA and cost synergies for 2026 and ruled out cable asset sales, while the market focused on leverage metrics and integration risks. PSKY traded at $13.23, down 2.03%, as investors weighed valuation against the company's higher debt burden.

Lockheed Martin shares climbed sharply in premarket trading on March 2, 2026, after U.S. and Israeli forces carried out coordinated strikes on Iran, driving a broad rally in defense stocks. The stock traded at $702.00 before the open, up $47.23 or 7.21% from its prior close of $658.08, and has already moved above the one-year average analyst target of $657.58. Investors are positioning for the possibility of expanded U.S. military spending, with Lockheed posting a 36.06% year-to-date gain and a 51.74% one-year return.

On February 27, 2026, Amazon.com, Inc. said it would invest $50 billion in OpenAI as part of the AI firm's $110 billion private funding round, valuing OpenAI at $730 billion pre-money. The multi-year arrangement also designates Amazon Web Services as OpenAI's exclusive third-party cloud provider and expands OpenAI's AWS usage by $100 billion over eight years. Amazon shares traded around $208.21 with a modest intraday gain and a market cap near $2.218 trillion following the announcement.

On February 27, 2026, Moderna's stock fluctuated as the European Medicines Agency's CHMP issued a positive opinion for mCOMBRIAX, its combination influenza and COVID-19 vaccine for adults 50 and older. The shares initially spiked but then traded at $51.06, down 1.27% in early U.S. trading, even as Phase 3 data supported the recommendation and analysts remained divided on the company's outlook.